Remed Co.,Ltd. (KOSDAQ:302550)

Remed Statistics

Total Valuation

Remed has a market cap or net worth of KRW 89.32 billion. The enterprise value is 84.81 billion.

Market Cap	89.32B
Enterprise Value	84.81B

Important Dates

The next estimated earnings date is Wednesday, August 12, 2026.

Earnings Date	Aug 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Remed has 30.91 million shares outstanding. The number of shares has decreased by -3.45% in one year.

Current Share Class	30.91M
Shares Outstanding	30.91M
Shares Change (YoY)	-3.45%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	36.09%
Owned by Institutions (%)	0.17%
Float	19.75M

Valuation Ratios

The trailing PE ratio is 95.50.

PE Ratio	95.50
Forward PE	n/a
PS Ratio	3.54
PB Ratio	2.13
P/TBV Ratio	2.33
P/FCF Ratio	129.22
P/OCF Ratio	59.17
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.32, with an EV/FCF ratio of 122.69.

EV / Earnings	71.48
EV / Sales	3.36
EV / EBITDA	34.32
EV / EBIT	82.13
EV / FCF	122.69

Financial Position

The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.14.

Current Ratio	3.69
Quick Ratio	2.71
Debt / Equity	0.14
Debt / EBITDA	2.39
Debt / FCF	8.53
Interest Coverage	1.27

Financial Efficiency

Return on equity (ROE) is 1.80% and return on invested capital (ROIC) is 2.96%.

Return on Equity (ROE)	1.80%
Return on Assets (ROA)	1.16%
Return on Invested Capital (ROIC)	2.96%
Return on Capital Employed (ROCE)	2.20%
Weighted Average Cost of Capital (WACC)	7.94%
Revenue Per Employee	274.32M
Profits Per Employee	12.90M
Employee Count	92
Asset Turnover	0.45
Inventory Turnover	1.56

Taxes

Income Tax	-204.71M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.33% in the last 52 weeks. The beta is 0.64, so Remed's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-14.33%
50-Day Moving Average	3,017.50
200-Day Moving Average	3,166.15
Relative Strength Index (RSI)	46.41
Average Volume (20 Days)	106,810

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Remed had revenue of KRW 25.24 billion and earned 1.19 billion in profits. Earnings per share was 30.26.

Revenue	25.24B
Gross Profit	14.17B
Operating Income	1.03B
Pretax Income	559.35M
Net Income	1.19B
EBITDA	2.47B
EBIT	1.03B
Earnings Per Share (EPS)	30.26

Balance Sheet

The company has 12.38 billion in cash and 5.89 billion in debt, with a net cash position of 6.49 billion or 209.95 per share.

Cash & Cash Equivalents	12.38B
Total Debt	5.89B
Net Cash	6.49B
Net Cash Per Share	209.95
Equity (Book Value)	41.91B
Book Value Per Share	1,289.17
Working Capital	21.02B

Cash Flow

In the last 12 months, operating cash flow was 1.51 billion and capital expenditures -818.25 million, giving a free cash flow of 691.24 million.

Operating Cash Flow	1.51B
Capital Expenditures	-818.25M
Depreciation & Amortization	1.44B
Net Borrowing	269.44M
Free Cash Flow	691.24M
FCF Per Share	22.37

Margins

Gross margin is 56.13%, with operating and profit margins of 4.09% and 4.70%.

Gross Margin	56.13%
Operating Margin	4.09%
Pretax Margin	2.22%
Profit Margin	4.70%
EBITDA Margin	9.79%
EBIT Margin	4.09%
FCF Margin	2.74%

Dividends & Yields

Remed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	3.45%
Shareholder Yield	3.45%
Earnings Yield	1.33%
FCF Yield	0.77%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on December 8, 2023. It was a forward split with a ratio of 5.

Last Split Date	Dec 8, 2023
Split Type	Forward
Split Ratio	5

Scores

Remed has an Altman Z-Score of 5.98 and a Piotroski F-Score of 6.

Altman Z-Score	5.98
Piotroski F-Score	6